Publications

Showing 301 to 310 of 555 Publications
Title Authors
CCNA Researchers* / CCNA Trainees**
Year Journal
The amyloid-ẞ degradation intermefdiate Aẞ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease
Kirabali T, Rigotti S, Siccoli A, Liebsch F, Shobo A, Hock C, Nitsch RM, Multhaup G*, Kulic L 2019 Acta Neuropathology Communications
The comprehensive assessment of neurodegeneration and dementia: Canadian cohort study
Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, Mcgilton K, Rockwood K, tierney MC, Andrew MK, Hsuing GYR, Camicioli R, Smith EE, Fogarty J, Lindsay J, Best S, Evans A, Das S, Mohaddes Z, Pilon R, Poirier J, Philips NA, McNamara E, Dixon RA, Duchesne S, MacKenzie I, Rylett JR 2019 Canadian Journal of Neurological Sciences
Long-term care admissions following hospitalization: The role of social vulnerability
Godin J, Theou O, Black K, McNeil SA, Andrew MK 2019 Healthcare
Therapeutic trial design for frontotemporal dementia and related disorders
Desmarais P, Rohrer JD, Nguyen QD, Herrmann N, Stuss DT, Lang AE, Boxer AL, Dickerson BC, Rosen H, van Swieten JC, Meeter LH, Borroni B, Tartaglia MC, Feldman HH, Black SE, Masellis M 2019 Journal of Neurology, Neurosurgery, and Psychiatry
Relationship Between Mood, Thinking, and Walking: A Systematic Review Examining Depressive Symptoms, Executive Function, and Gait
Patience J, Lai K S P, Russell E, Vasudev A, Montero-Odasso M, Burhan AM 2019 American Journal of Geriatric Psychiatry
Kinect Project: People with dementia or MCI learning to play group motion-based games
Dove E, Astell AJ 2019 Alzheimer's and Dementia
Investigating the Safety and Efficacy of Nabilone for the Treatment of Agitation in Patients With Moderate-To-Severe Alzheimer’s Disease: Study Protocol for a Cross-Over Randomized Controlled Trial
Ruthirakuhan MT, Herrmann N, Gallagher D, Andreazza AC, Kiss A, Verhoeff NPLG, Black SE, Lanctôt KL 2019 Contemporary Clinical Trials Communications
Randomized placebo-controlled trial of nabilone for agitation in Alzheimer’s disease
Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff, NPLG, Kiss A, Black SE, Lanctôt K 2019 American Journal of Geriatric Psychiatry
Regional progression of Alzheimer’s disease confounds behavioural rescue after amyloid attenuation
C. D. Morrone, P. Bazzigaluppi, T. L. Beckett, M. E. Hill, M. M. Koletar, B. Stefanovic, J. McLaurin 2019 Brain
White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal
N. Ivanova, Q. Liu, C. Agca, Y. Agca, E.G. Noble, S.N. Whitehead and D.F. Cechetto 2020 Journal of Neuroinflammation
Showing 301 to 310 of 555 Publications
Go back to top